Experiment data
|
|
| Table 5.23 E. coli disease (ETEC, EPEC, EIEC) in the human oral data
|
| Dose(CFU)
|
Dead
|
Survived
|
Total
|
| 1 (104)
|
0
|
5
|
5
|
| 1 (104)
|
0
|
5
|
5
|
| 1 (106)
|
0
|
5
|
5
|
| 1 (106)
|
1
|
8
|
9
|
| 1 (108)
|
5
|
3
|
8
|
| 1 (108)
|
1
|
4
|
5
|
| 1 (108)
|
3
|
2
|
5
|
| 1 (108)
|
2
|
3
|
5
|
| 1.4 (108)
|
6
|
2
|
8
|
| 2.7 (108)
|
9
|
7
|
16
|
| 1.7 (109)
|
5
|
2
|
7
|
| 5.3 (109)
|
6
|
2
|
8
|
| 1 (1010)
|
4
|
1
|
5
|
| 1 (1010)
|
3
|
2
|
5
|
| 1.6 (1010)
|
7
|
1
|
8
|
| DuPont et al. (1971), June et al. (1953), Graham et al. (1983)
|
|
| Table 5.26 EPEC disease in the human oral data
|
| Dose(CFU)
|
Dead
|
Survived
|
Total
|
| 1 (106)
|
0
|
4
|
4
|
| 1 (106)
|
1
|
4
|
5
|
| 1 (108)
|
1
|
4
|
5
|
| 5 (108)
|
3
|
2
|
5
|
| 2.5 (109)
|
6
|
0
|
6
|
| 1 (1010)
|
3
|
2
|
5
|
| 1 (1010)
|
5
|
0
|
5
|
| 2 (1010)
|
2
|
0
|
2
|
| DuPont et al. (1971), June et al. (1953), Graham et al. (1983)
|
|
| Table 5.29 EPEC disease in the human oral data
|
| Dose(CFU)
|
Dead
|
Survived
|
Total
|
| 1 (106)
|
3
|
3
|
6
|
| 1 (107)
|
6
|
9
|
15
|
| 1 (108)
|
6
|
1
|
7
|
| 1 (108)
|
7
|
4
|
11
|
| 1 (108)
|
7
|
5
|
12
|
| 1 (108)
|
9
|
3
|
12
|
| 1 (108)
|
6
|
3
|
9
|
| 1 (108)
|
4
|
2
|
6
|
| 1 (108)
|
3
|
1
|
4
|
| 1 (108)
|
4
|
0
|
4
|
| 2.7 (108)
|
9
|
7
|
16
|
| 5 (108)
|
19
|
8
|
27
|
| 1 (109)
|
5
|
3
|
8
|
| 1 (109)
|
7
|
1
|
8
|
| 1 (109)
|
5
|
5
|
10
|
| 1 (1010)
|
8
|
0
|
8
|
| 1 (1010)
|
5
|
4
|
9
|
| 1 (1010)
|
9
|
3
|
12
|
| 1 (1010)
|
9
|
5
|
14
|
| Coster et al. (2007), Graham et al. (1983), Levine et al. (1979), Levine et al. (1980), Clements et al. (1981), Levine et al. (1982)
|
|
| Table 5.32 ETEC disease, unbuffered, in the human oral data
|
| Dose(CFU)
|
Dead
|
Survived
|
Total
|
| 1 (106)
|
0
|
4
|
4
|
| 1 (108)
|
1
|
4
|
5
|
| 1 (108)
|
2
|
3
|
5
|
| 1 (108)
|
3
|
2
|
5
|
| 1.4 (108)
|
6
|
2
|
8
|
| 1.7 (109)
|
5
|
2
|
7
|
| 5.3 (109)
|
6
|
2
|
8
|
| 1 (1010)
|
4
|
1
|
5
|
| 1 (1010)
|
3
|
2
|
5
|
| 1 (1010)
|
4
|
1
|
5
|
| 1.6 (1010)
|
7
|
1
|
8
|
| DuPont et al. (1971), June et al. (1953), Levine et al. (1977)
|
|
| Table 5.35 ETEC infection, unbuffered, in the human oral data
|
| Dose(CFU)
|
Dead
|
Survived
|
Total
|
| 1 (106)
|
0
|
4
|
4
|
| 1 (106)
|
1
|
4
|
5
|
| 1 (108)
|
1
|
4
|
5
|
| 5 (108)
|
3
|
2
|
5
|
| 2.5 (109)
|
6
|
0
|
6
|
| 1 (1010)
|
9
|
1
|
10
|
| 1 (1010)
|
9
|
5
|
14
|
| 1 (1010)
|
3
|
2
|
5
|
| 1 (1010)
|
5
|
0
|
5
|
| 2 (1010)
|
2
|
0
|
2
|
| 2.3 (1010)
|
14
|
5
|
19
|
| Tacket et al. (2000), Donnenberg et al. (1998), Bieber et al. (1998), Levine et al. (1978)
|
|
| Table 5.38 EPEC, infection, buffered, in the human oral data
|
| Dose(CFU)
|
Dead
|
Survived
|
Total
|
| 1 (106)
|
3
|
1
|
4
|
| 1 (106)
|
5
|
0
|
5
|
| 1 (106)
|
4
|
1
|
5
|
| 1 (108)
|
5
|
0
|
5
|
| 1 (108)
|
5
|
0
|
5
|
| 9 (108)
|
8
|
0
|
8
|
| 1 (1010)
|
10
|
0
|
10
|
| 1 (1010)
|
9
|
0
|
9
|
| 1 (1010)
|
14
|
0
|
14
|
| 1 (1010)
|
5
|
0
|
5
|
| 1 (1010)
|
5
|
0
|
5
|
| 1 (1010)
|
5
|
0
|
5
|
| 2.3 (1010)
|
19
|
0
|
19
|
| Tacket et al. (2000), Donnenberg et al. (1993), Levine et al. (1978)
|
|
|
References
Bieber, D. et al., 1998. Type IV pili, transient bacterial aggregates, and virulence of enteropathogenic Escherichia coli. Science (New York, N.Y.), 280(5372), pp.2114-2118. Full text
Clements, M.L. et al., 1981. Lactobacillus prophylaxis for diarrhea due to enterotoxigenic Escherichia coli. Antimicrobial Agents and Chemotherapy, 20(1), pp.104-108. Full text
Coster, T.S. et al., 2007. Immune response, ciprofloxacin activity, and gender differences after human experimental challenge by two strains of enterotoxigenic Escherichia coli. Infection and Immunity, 75(1), pp.252-259. Full text
DuPont, H.L. et al., 1971. Pathogenesis of Escherichia coli diarrhea. The New England Journal of Medicine, 285(1), pp.1-9. Abstract
Donnenberg, M.S. et al., 1993. Role of the eaeA gene in experimental enteropathogenic Escherichia coli infection. The Journal of Clinical Investigation, 92(3), pp.1412-1417. Full text
Graham, D.Y., Estes, M.K. & Gentry, L.O., 1983. Double-blind comparison of bismuth subsalicylate and placebo in the prevention and treatment of enterotoxigenic Escherichia coli-induced diarrhea in volunteers. Gastroenterology, 85(5), pp.1017-1022. Abstract
June, R.C., Ferguson, W.W. & Worfel, M.T., 1953. Experiments in feeding adult volunteers with Escherichia coli 55, B5, a coliform organism associated with infant diarrhea. American Journal of Hygiene, 57(2), pp.222-236. Full text
Ferguson, W.W. & June, R.C., 1952. Experiments on feeding adult volunteers with Escherichia coli 111, B4, a coliform organism associated with infant diarrhea. American Journal of Hygiene, 55(2), pp.155-169. Full text
Levine, M.M. et al., 1978. Escherichia coli strains that cause diarrhoea but do not produce heat-labile or heat-stable enterotoxins and are non-invasive. Lancet, 1(8074), pp.1119-1122. Abstract
Levine, M.M. et al., 1977. Diarrhea caused by Escherichia coli that produce only heat-stable enterotoxin. Infection and Immunity, 17(1), pp.78-82. Full text
Levine, M.M. et al., 1982. Reactogenicity, immunogenicity and efficacy studies of Escherichia coli type-1 somatic pili parenteral vaccine in man. Scandinavian Journal of Infectious Diseases, Suppl. 33, pp.83-95. Abstract
Levine, M.M. et al., 1980. Lack of person-to-person transmission of enterotoxigenic Escherichia coli despite close contact. American Journal of Epidemiology, 111(3), pp.347-355. Full text
Tacket, C.O. et al., 2000. Role of EspB in experimental human enteropathogenic Escherichia coli infection. Infection and Immunity, 68(6), pp.3689-3695. Full text
